SARS-CoV-2 Vaccination Status and MIS-C Incidence: A Systematic Review
Variant emergence, not vaccine deployment, drives episodic positive selection on the SARS-CoV-2 spike at provincial scale in Canada
Orally Bioavailable SARS-CoV-2 Protease Inhibitors Bearing a Hydroxymethyl Ketone Warhead
Environmental stochasticity can account for patterns of within-host respiratory virus evolution
Who infected the reported cases? Evidence from 678,482 COVID-19 cases with identified infector collected in routine surveillance in the Netherlands, 2020-2022.
Cross-resistance patterns in SARS-CoV-2 against 3CL protease inhibitors
Cross-resistance patterns in SARS-CoV-2 against 3CL protease inhibitors
Minority children have higher odds of severe post-COVID complications, study suggests
Myocarditis rates surged during COVID and stayed high, study suggests
Early antiviral use may lower risk of long COVID in mildly ill patients, aid recovery from infection